HIGH-STAKES DRAMA SURROUNDING 23ANDME’S BANKRUPTCY—including CEO Anne Wojcicki resigning to try to bid for the company she cofounded and state prosecutors urging caution about the data privacy of the company’s customers—brings up a fundamental question regarding direct- to-consumer (DTC) genetic testing: Is the consumer market strong enough to support long-term growth for DTC firms? Hints […]
As 23andMe Faces Bankruptcy, Home Testing Shows Warts
However, confidence in direct-to-consumer tests does not seem to be wavering
- By Robert Michel
- > From the Volume XXXII, No. 7 - May 12, 2025 Issue
